Insider · CIK 0001298146

Pereira Brian JG

Reports to the SEC for 6 companies · WINSTON SALEM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001298146

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-20	PROKPROKIDNEY CORP.S Sale	Director	SSale	−223K sh	$1.42	−$317K	0
2026-08-20	PROKPROKIDNEY CORP.S Sale	Director	SSale	−27.1K sh	$1.42	−$38.4K	0
2026-08-19	PROKPROKIDNEY CORP.S Sale	Director	SSale	−223K sh	$1.44	−$321K	222,948
2026-08-19	PROKPROKIDNEY CORP.S Sale	Director	SSale	−27.1K sh	$1.44	−$39K	27,052
2026-08-18	PROKPROKIDNEY CORP.S Sale	Director	SSale	−229K sh	$1.37	−$314K	445,897
2026-08-18	PROKPROKIDNEY CORP.S Sale	Director	SSale	−27.8K sh	$1.37	−$38.2K	54,103
2026-08-04	PROKPROKIDNEY CORP.C Conversion	Director	CConversion	+81.9K sh	—	—	81,929
2026-08-04	PROKPROKIDNEY CORP.C Conversion	Director	CConversion	+675K sh	—	—	675,235
2026-08-04	PROKPROKIDNEY CORP. · Class B Common StockC Conversion	Director	CConversion	−81.9K sh	—	—	0
2026-08-04	PROKPROKIDNEY CORP. · Common Units in ProKidney Holdings, LLCC Conversion	Director	CConversion	−81.9K sh	—	—	0
2026-08-04	PROKPROKIDNEY CORP. · Class B Common StockC Conversion	Director	CConversion	−675K sh	—	—	0
2026-08-04	PROKPROKIDNEY CORP. · Common Units in ProKidney Holdings, LLCC Conversion	Director	CConversion	−675K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2026-05-28	PROKPROKIDNEY CORP. · Director stock option (right to buy)A Award	Director	AAward	+135K sh	—	—	135,000
2025-11-13	PROKPROKIDNEY CORP.S Sale	Director	SSale	−448K sh	$2.37	−$1.06M	0
2025-11-13	PROKPROKIDNEY CORP.S Sale	Director	SSale	−54.3K sh	$2.37	−$129K	0
2025-11-12	PROKPROKIDNEY CORP.S Sale	Director	SSale	−227K sh	$2.72	−$619K	447,803
2025-11-12	PROKPROKIDNEY CORP.S Sale	Director	SSale	−27.6K sh	$2.72	−$75.2K	54,333
2025-10-01	KalVista Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-05-29	PROKPROKIDNEY CORP. · Director stock option (right to buy)A Award	Director	AAward	+126K sh	—	—	125,862
2025-02-04	PROKPROKIDNEY CORP.C Conversion	Director	CConversion	+81.9K sh	—	—	81,928
2025-02-04	PROKPROKIDNEY CORP.C Conversion	Director	CConversion	+675K sh	—	—	675,234
2025-02-04	PROKPROKIDNEY CORP. · Class B Ordinary SharesC Conversion	Director	CConversion	−81.9K sh	—	—	81,929
2025-02-04	PROKPROKIDNEY CORP. · Common Units in ProKidney LPC Conversion	Director	CConversion	−81.9K sh	—	—	81,929
2025-02-04	PROKPROKIDNEY CORP. · Class B Ordinary SharesC Conversion	Director	CConversion	−675K sh	—	—	675,235
2025-02-04	PROKPROKIDNEY CORP. · Common Units in ProKidney LPC Conversion	Director	CConversion	−675K sh	—	—	675,235
2024-10-03	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-05-30	PROKPROKIDNEY CORP. · Director stock option (right to buy)A Award	Director	AAward	+62.6K sh	—	—	62,558
2023-09-26	KalVista Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-06-29	PROKPROKIDNEY CORP. · Director stock option (right to buy)A Award	Director	AAward	+48.1K sh	—	—	48,128
2022-10-13	KalVista Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-07-11	PROKPROKIDNEY CORP. · Class B Ordinary SharesA Award	Director	AAward	+1.51M sh	—	—	1,514,326
2022-07-11	PROKPROKIDNEY CORP. · Common Units in ProKidney LPA Award	Director	AAward	+1.51M sh	—	—	1,514,326
2021-09-30	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-10-01	KalVista Pharmaceuticals, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2020-04-15	ABEOABEONA THERAPEUTICS INC. · Employee Stock Option (right to buy)A Award	Director, Executive Chairman	AAward	+930K sh	—	—	930,000
2019-02-01	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2014-03-04	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2013-12-20	ALBIREO PHARMA, INC.S Sale	Director	SSale	−4,734 sh	$2.26	−$10.7K	0
2013-03-05	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2012-03-08	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2011-12-16	ALBIREO PHARMA, INC.S Sale	Director	SSale	−15K sh	$0.65	−$9,750	18,937
2011-09-30	ALBIREO PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,937 sh	—	—	3,937
2011-09-30	ALBIREO PHARMA, INC.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,937 sh	—	—	0

Recent filings

Accepted (ET)
Aug 204
Pereira Brian JG0001193125-26-359349
SEC(opens sec.gov)
Aug 64
Pereira Brian JG0001193125-26-336856
SEC(opens sec.gov)
Jun 114
Pereira Brian JG0001298146-26-000002
SEC(opens sec.gov)
May 294
Pereira Brian JG0001193125-26-248215
SEC(opens sec.gov)

Companies

Address

C/O PROKIDNEY CORP 2000 FRONTIS PLAZA BLVD, SUITE 250

WINSTON SALEM, NC, 27103